Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 1/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.30 |
| ▸ | HTT | P42858 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL588269 | 0.90 | MAPK1 (0.36) | MAPK1HPGDMEN1KMT2AALDH1A1 | |
| SCHEMBL587541 | 0.88 | HSD11B1 (0.33) | CYP1A2CYP2C9HPGDCYP2C19ALDH1A1 | |
| SCHEMBL588675 | 0.87 | MAPK1 (0.42) | MAPK1MEN1KMT2AALDH1A1SMN1; SMN2 | |
| SCHEMBL6495177 | 0.81 | CYP1A2 (0.36) | MAPK1CYP1A2CYP2C9HPGDCYP2C19 | |
| SCHEMBL587840 | 0.80 | MAPT (0.32) | MAPK1KMT2AMAPT | |
| SCHEMBL587521 | 0.80 | SMN1; SMN2 (0.38) | HPGDMEN1KMT2AALDH1A1SMN1; SMN2 | |
| SCHEMBL587621 | 0.78 | HSD11B1 (0.35) | MEN1KMT2AALDH1A1SMN1; SMN2POLB | |
| SCHEMBL6493539 | 0.76 | MAPK1 (0.33) | MAPK1CYP1A2CYP2C9HPGDCYP2C19 | |
| SCHEMBL588676 | 0.75 | MAPT (0.38) | MAPK1MEN1KMT2AALDH1A1SMN1; SMN2 | |
| SCHEMBL6482175 | 0.74 | MEN1 (0.39) | MAPK1CYP1A2CYP2C9HPGDCYP2C19 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2081925-B1 | Benzoylpyrazoles, their use as herbicides, and intermediates | BAYER CROPSCIENCE AG (DE) | 2012-02-15 | — | — | EP | disclosed |
| US-8084398-B2 | Benzoylpyrazoles and herbicide | BAYER CROPSCIENCE AG (DE) | 2011-12-27 | — | — | US | disclosed |
| US-20100094023-A1 | BENZOYLPYRAZOLES AND HERBICIDE | BAYER CROPSCIENCE AG (DE) | 2010-04-15 | — | — | US | disclosed |
| EP-2081925-A1 | BENZOYLPYRAZOLES, THEIR USE AS AS HERBICIDES, AND INTERMEDIATES | Bayer CropScience AG (DE) | 2009-07-29 | — | — | EP | disclosed |
| WO-2008043456-A1 | BENZOYLPYRAZOLES, THEIR USE AS AS HERBICIDES, AND INTERMEDIATES | BAYER CROPSCIENCE AG (DE) | 2008-04-17 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100094023-A1 | BENZOYLPYRAZOLES AND HERBICIDE | ATL3, AHR, HACL2 | MAPK1 2176/4885CYP1A2 56/4885CYP2C9 441/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.